CI Cigna

Q2 2025 10-Q

Filed: Jul 31, 2025Period ending Jun 30, 2025

Financials

Hospital & Medical Service PlansSEC EDGAR

Cigna (CI) 10-Q quarterly report for Q2 2025, filed with SEC EDGAR on Jul 31, 2025 for the fiscal period ending Jun 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q2 2025 10-Q

Management Discussion & Analysis

• Revenue and profitability data not disclosed in provided MD&A excerpt
• No segment or product line performance figures included

+2 more insights

Risk Factors

• Newly added risk: Decrease in debt securities carrying value from $9.4B to $8.4B due to HCSC transaction
• Most materially updated risk: Commercial mortgage loan portfolio market value below carrying value amid rising interest rates, yet stable credit quality

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$67.2B

▲ +11.0% YoY▲ +2.6% QoQ

Net Income

$1.5B

▼ -1.0% YoY▲ +15.8% QoQ

Operating Margin

3.4%

▼ -55bp YoY▲ +42bp QoQ

Net Margin

2.3%

▼ -28bp YoY▲ +26bp QoQ

EPS (Diluted)

$5.70

▲ +5.6% YoY▲ +17.5% QoQ

Operating Cash Flow

-$1.9B

▼ -811.7% YoY▼ -198.2% QoQ

Source: XBRL data from Cigna Q2 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Cigna Quarterly Reports

Q3 2025 10-Q

Q1 2025 10-Q

Get deeper insights on Cigna

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.